Zheng, T., Li, D., He, Z., & Zhao, S. (2019). miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway. Cancer Cell Int.
Citação norma ChicagoZheng, Tian-Liang, De-Ping Li, Zhan-Feng He, and Song Zhao. "MiR-145 Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin Through Directly Inhibiting PI3K/AKT Signaling Pathway." Cancer Cell Int 2019.
MLA CitationZheng, Tian-Liang, De-Ping Li, Zhan-Feng He, and Song Zhao. "MiR-145 Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin Through Directly Inhibiting PI3K/AKT Signaling Pathway." Cancer Cell Int 2019.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.